ArticleSmall science2026
Discovery of Novel Ionizable Lipids for Lipid Nanoparticles: Lipophilicity as a Predictor of Squaramide Head Group Lipid Clearance.
Article in Small science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ionizable lipids are a critical component of lipid nanoparticles (LNPs) for messenger RNA (mRNA) delivery, driving cellular uptake, endosomal escape, and tolerability. It is well-known that chemical modifications to ionizable lipids profoundly affect both potency and safety profiles. However, the lack of reliable predictive tools, limited understanding of lipid behavior, and the intrinsic complexity of LNPs remain major challenges in LNP development. Among these, in vivo lipid clearance is a critical yet poorly understood factor influencing long-term safety of mRNA loaded LNPs, particularly with respect to their accumulation. Impaired clearance leading to lipid accumulation can pose safety liabilities and contribute to long-term toxicity. To address this, we investigated lipophilic properties of squaramide head group ionizable lipids with ester linkers as surrogates for in vivo clearance. We demonstrate that lipid clearance can be tuned by chemical modification and is predictable from simple lipophilicity calculation. To our knowledge, this represents the first computationally driven approach predicting lipid properties relevant to both efficacy and long-term safety within the current competitive landscape.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.